Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at the University of Utah is evaluating a structured exercise program to improve zest and energy in patients with metastatic breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: University of Utah | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING